X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5022) 5022
Publication (270) 270
Book Review (36) 36
Book Chapter (17) 17
Conference Proceeding (10) 10
Book / eBook (8) 8
Dissertation (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4628) 4628
male (2900) 2900
nasopharyngeal carcinoma (2767) 2767
female (2512) 2512
index medicus (2367) 2367
middle aged (2230) 2230
adult (2182) 2182
oncology (1695) 1695
cancer (1675) 1675
aged (1498) 1498
nasopharyngeal neoplasms - pathology (1451) 1451
carcinoma (1287) 1287
adolescent (992) 992
radiotherapy (841) 841
prognosis (813) 813
nasopharyngeal neoplasms - radiotherapy (711) 711
otorhinolaryngology (692) 692
chemotherapy (618) 618
neoplasm staging (610) 610
nasopharyngeal neoplasms - genetics (584) 584
nasopharyngeal neoplasms - diagnosis (572) 572
nasopharyngeal neoplasms - virology (570) 570
child (560) 560
retrospective studies (559) 559
tumors (547) 547
metastasis (541) 541
care and treatment (523) 523
treatment outcome (515) 515
epstein-barr virus (512) 512
young adult (505) 505
animals (502) 502
expression (500) 500
nasopharyngeal neoplasms - therapy (499) 499
research (494) 494
nasopharyngeal cancer (482) 482
surgery (475) 475
herpesvirus 4, human - genetics (442) 442
nasopharyngeal neoplasms - drug therapy (432) 432
analysis (430) 430
epstein-barr-virus (429) 429
cell line, tumor (424) 424
health aspects (403) 403
radiology, nuclear medicine & medical imaging (403) 403
nasopharyngeal neoplasms - metabolism (396) 396
survival (396) 396
follow-up studies (394) 394
head (391) 391
nasopharyngeal neoplasms - immunology (389) 389
nasopharyngeal neoplasms - blood (385) 385
risk factors (383) 383
nasopharyngeal neoplasms - surgery (382) 382
diagnosis (377) 377
aged, 80 and over (369) 369
nasopharyngeal neoplasms - mortality (368) 368
radiation therapy (366) 366
genetic aspects (363) 363
disease-free survival (347) 347
herpesvirus 4, human - immunology (345) 345
mice (310) 310
patients (310) 310
pathology (308) 308
carcinoma - pathology (304) 304
case-control studies (299) 299
medicine (296) 296
research article (293) 293
proteins (290) 290
squamous-cell carcinoma (286) 286
apoptosis (280) 280
immunohistochemistry (278) 278
radiation-therapy (276) 276
medicine & public health (273) 273
polymerase chain reaction (266) 266
survival rate (258) 258
dna (256) 256
cancer therapies (255) 255
nasopharyngeal neoplasms - diagnostic imaging (251) 251
magnetic resonance imaging (250) 250
radiation (248) 248
herpesvirus 4, human - isolation & purification (246) 246
gene expression (245) 245
stomatognathic diseases (244) 244
combined modality therapy (243) 243
intensity-modulated radiotherapy (240) 240
medical prognosis (240) 240
gene expression regulation, neoplastic (236) 236
development and progression (231) 231
hematology, oncology and palliative medicine (231) 231
medicine, research & experimental (229) 229
tomography, x-ray computed (229) 229
neoplasms. tumors. oncology. including cancer and carcinogens (227) 227
cells (225) 225
otorhinolaryngologic diseases (224) 224
medical research (217) 217
survival analysis (217) 217
neck (216) 216
antineoplastic combined chemotherapy protocols - therapeutic use (211) 211
cell biology (210) 210
therapy (209) 209
nasopharyngeal neoplasms - epidemiology (204) 204
studies (204) 204
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4753) 4753
Chinese (183) 183
French (26) 26
German (21) 21
Russian (17) 17
Polish (8) 8
Japanese (6) 6
Italian (4) 4
Serbian (4) 4
Spanish (4) 4
Dutch (3) 3
Turkish (3) 3
Danish (2) 2
Arabic (1) 1
Czech (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2011, Volume 81, Issue 1, pp. 126 - 134
Purpose To perform a comprehensive cognitive function (CF) assessment in patients who were relapse free after curative intent radiotherapy (RT) or... 
Radiology | Hematology, Oncology and Palliative Medicine | Squamous cell carcinoma of the head and neck | Chemotherapy | Neuropsychological testing | Radiotherapy | Cognitive dysfunction | PROPHYLACTIC CRANIAL IRRADIATION | ADJUVANT CHEMOTHERAPY | DRIVING PERFORMANCE | FOLLOW-UP | CELL LUNG-CANCER | BREAST-CANCER | NASOPHARYNGEAL CARCINOMA | ONCOLOGY | NEUROCOGNITIVE FUNCTION | LOW-GRADE GLIOMA | QUALITY-OF-LIFE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Laryngeal Neoplasms - radiotherapy | Pharyngeal Neoplasms - radiotherapy | Cerebellum - radiation effects | Prospective Studies | Humans | Middle Aged | Male | Pharyngeal Neoplasms - drug therapy | Antineoplastic Agents - administration & dosage | Cognition - physiology | Laryngeal Neoplasms - drug therapy | Neoplasms, Squamous Cell - pathology | Carcinoma - drug therapy | Carcinoma - blood | Affect - physiology | Head and Neck Neoplasms - drug therapy | Cognition - drug effects | Neoplasms, Squamous Cell - blood | Head and Neck Neoplasms - pathology | Carcinoma, Squamous Cell | Neuropsychological Tests | Cognition Disorders - diagnosis | Memory Disorders - etiology | Hypopharyngeal Neoplasms - pathology | Quality of Life | Pharyngeal Neoplasms - pathology | Hypopharyngeal Neoplasms - drug therapy | Temporal Lobe - drug effects | Laryngeal Neoplasms - blood | Cerebellum - drug effects | Hypopharyngeal Neoplasms - blood | Cisplatin - administration & dosage | Feasibility Studies | Laryngeal Neoplasms - pathology | Squamous Cell Carcinoma of Head and Neck | Head and Neck Neoplasms - blood | Antineoplastic Agents - adverse effects | Cognition Disorders - etiology | Neoplasms, Squamous Cell - drug therapy | Neoplasms, Squamous Cell - radiotherapy | Female | Carcinoma - pathology | Cognition - radiation effects | Affect - drug effects | Pharyngeal Neoplasms - blood | Affect - radiation effects | Carcinoma - radiotherapy | Combined Modality Therapy - adverse effects | Head and Neck Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - radiotherapy | Cisplatin - adverse effects | Aged | Combined Modality Therapy - methods | Temporal Lobe - radiation effects | Care and treatment | Squamous cell carcinoma | Cancer | BODY FLUIDS | HEAD | NERVOUS SYSTEM | RADIATION DOSES | MEDICINE | THERAPY | CEREBELLUM | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | COMBINED THERAPY | BRAIN | RADIOLOGY | BLOOD | NEOPLASMS | BIOLOGICAL MATERIALS | CENTRAL NERVOUS SYSTEM | STANDARD OF LIVING | CHEMOTHERAPY | NUCLEAR MEDICINE | ORGANS | DISEASES | DOSES | CARCINOMAS | NECK | DOSIMETRY | BODY | MATERIALS
Journal Article
Head & Neck, ISSN 1043-3074, 02/2017, Volume 39, Issue 2, pp. 247 - 253
Background The purpose of this study was to analyze the relationship between pretreatment inflammatory markers and the prognosis of patients with... 
neutrophil‐to‐lymphocyte ratio (NLR) | platelet‐to‐lymphocyte ratio (PLR) | chemoradiotherapy | head and neck cancer | lymphocyte‐to‐monocyte ratio (LMR) | lymphocyte-to-monocyte ratio (LMR) | neutrophil-to-lymphocyte ratio (NLR) | platelet-to-lymphocyte ratio (PLR) | SURVIVAL | SURGERY | TUMOR PROGRESSION | INFILTRATING LYMPHOCYTES | PERFORMANCE | NASOPHARYNGEAL CARCINOMA | COLORECTAL-CANCER | OTORHINOLARYNGOLOGY | SQUAMOUS-CELL CARCINOMA | B7-H1 | INFLAMMATORY RESPONSE | PD-1 | Laryngeal Neoplasms - blood | Oropharyngeal Neoplasms - therapy | Monocytes - cytology | Humans | Middle Aged | Oropharyngeal Neoplasms - mortality | Male | Hypopharyngeal Neoplasms - mortality | Hypopharyngeal Neoplasms - blood | Laryngeal Neoplasms - therapy | Head and Neck Neoplasms - blood | Aged, 80 and over | Adult | Female | Retrospective Studies | Databases, Factual | Chemoradiotherapy - methods | Japan | Head and Neck Neoplasms - therapy | Hospitals, University | Inflammation Mediators - blood | Kaplan-Meier Estimate | Proportional Hazards Models | Neck Dissection - methods | Hypopharyngeal Neoplasms - therapy | Disease-Free Survival | Laryngectomy - methods | Platelet Count | Laryngeal Neoplasms - mortality | Survival Analysis | Lymphocyte Count | Oropharyngeal Neoplasms - blood | ROC Curve | Aged | Head and Neck Neoplasms - mortality | Cohort Studies | Preoperative Care - methods | Prognosis | Lymphocytes | Analysis | Cancer
Journal Article
International Journal of Cancer, ISSN 0020-7136, 03/2015, Volume 136, Issue 5, pp. E301 - E312
More than 75% of nasopharyngeal carcinoma (NPC) patients have already developed local or regional spread at diagnosis, which hampers effective treatment and... 
NPC | microRNA | biomarker | EBV BART | Epstein‐Barr virus | Biomarker | Epstein-Barr virus | CURRENT MANAGEMENT | FUTURE-DIRECTIONS | CHINA | 7TH EDITION | CELL-LINES | QUANTITATIVE-ANALYSIS | CANCER | STAGING SYSTEM | ONCOLOGY | DNA | EXPRESSION | Nasopharyngeal Neoplasms - genetics | Carcinoma | Herpesvirus 4, Human - genetics | Prognosis | Follow-Up Studies | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Nasopharyngeal Neoplasms - virology | Neoplasm Recurrence, Local - virology | Male | Chemoradiotherapy | Viral Load | Young Adult | Epstein-Barr Virus Infections - therapy | Nasopharyngeal Neoplasms - blood | Epstein-Barr Virus Infections - genetics | Adult | Female | Epstein-Barr Virus Infections - blood | Nasopharyngeal Carcinoma | Epstein-Barr Virus Infections - virology | Neoplasm Invasiveness | Nasopharyngeal Neoplasms - therapy | Neoplasm Recurrence, Local - therapy | Lymphatic Metastasis | Reverse Transcriptase Polymerase Chain Reaction | Biomarkers, Tumor - blood | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Neoplasm Recurrence, Local - genetics | Aged | Biomarkers, Tumor - genetics | MicroRNAs - blood | MicroRNAs - genetics | Neoplasm Staging | Proteins | Care and treatment | MicroRNA | Analysis | Diagnosis | Biological markers | Cancer | Biomarkers | Radiation therapy | Throat cancer | Medical diagnosis | MicroRNAs
Journal Article
Journal Article
Journal Article
Journal Article
Blood, ISSN 0006-4971, 02/2009, Volume 113, Issue 9, pp. 1957 - 1966
Epstein-Barr virus (EBV)-associated nasopharyngeal carcinoma (NPC) is the third most frequent virus-associated human malignancy. How this tumor escapes immune... 
MOLECULAR CHARACTERIZATION | ANTIGEN-PROCESSING FUNCTION | EPITHELIAL-CELLS | DENDRITIC CELLS | BURKITTS-LYMPHOMA | NUCLEAR ANTIGEN | REGULATORY T-CELLS | GENE-EXPRESSION | GALECTIN-9 SUPPRESSES | DISTINCT EXPRESSION | HEMATOLOGY | Exosomes - metabolism | Nasopharyngeal Neoplasms - metabolism | Apoptosis - drug effects | Receptors, Virus - metabolism | Blood Vessels - metabolism | Humans | Exosomes - pathology | Transplantation, Heterologous | CD4-Positive T-Lymphocytes - pathology | CD4-Positive T-Lymphocytes - immunology | Carcinoma - complications | Nasopharyngeal Neoplasms - blood | T-Lymphocytes, Helper-Inducer - immunology | Nasopharyngeal Neoplasms - complications | Protein Binding - drug effects | Galectins - immunology | Nasopharyngeal Neoplasms - immunology | Epstein-Barr Virus Infections - blood | T-Lymphocytes, Helper-Inducer - pathology | Diffusion | Tumor Escape - immunology | Carcinoma - blood | Carcinoma - immunology | Epstein-Barr Virus Infections - immunology | CD4-Positive T-Lymphocytes - metabolism | Galectins - antagonists & inhibitors | Hepatitis A Virus Cellular Receptor 2 | Antibodies - pharmacology | Animals | Apoptosis - immunology | Cell Line, Tumor | Receptors, Virus - immunology | Epstein-Barr Virus Infections - complications | Galectins - blood | Mice | Carcinoma - metabolism | HeLa Cells | Receptors, Virus - antagonists & inhibitors | Epstein-Barr Virus Infections - metabolism | Galectins - metabolism
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2012, Volume 49, Issue 7, pp. 1619 - 1626
Journal Article
Journal Article